跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
拓立珂 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Talquetamab Injection
Approved
生物制品
Talquetamab Injection
Janssen-Cilag International NV
🇨🇳 National Medical Products Administration
Approval Date
Feb 8, 2025
Approval ID
8h2lTuWQxXi
Company
Janssen-Cilag International NV
Type
生物制品
Approval Details
Approval Id
8h2lTuWQxXi
Approval Number
国药准字SJ20250003
Generic Name
塔奎妥单抗注射液
Generic Name En
Talquetamab Injection
Trade Name
拓立珂
Drug Type
生物制品
Dosage Form
注射剂
Strength
3mg(1.5ml)/瓶
Reg Date
2025-02-08
Expired Date
2030-02-07
Company Name
Janssen-Cilag International NV
Production Company Name
Patheon Manufacturing Services LLC
Company Detail Path
/organization/janssen-cilag-international-nv
Production Company Detail Path
/organization/patheon-manufacturing-services-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 8, 2025
Approval ID
8h2lTuWQxXi
Type
生物制品
Back to NMPA Approvals